 | • レポートコード：QYR9ST04419 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、胆管炎の世界市場について調査・分析し、胆管炎の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（急性胆管炎、原発性硬化性胆管炎、二次性硬化性胆管炎、再発性化膿性胆管炎）、用途別（臨床実習、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆管炎市場動向 ・主要企業別マーケットシェア ・胆管炎の種類別市場規模2014-2019 （急性胆管炎、原発性硬化性胆管炎、二次性硬化性胆管炎、再発性化膿性胆管炎） ・胆管炎の用途別市場規模2014-2019 （臨床実習、その他） ・胆管炎の北米市場：主要企業・種類別/用途別市場規模 ・胆管炎のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・胆管炎の中国市場：主要企業・種類別/用途別市場規模 ・胆管炎の日本国内市場：主要企業・種類別/用途別市場規模 ・胆管炎の東南アジア市場：主要企業・種類別/用途別市場規模 ・胆管炎のインド市場：主要企業・種類別/用途別市場規模 ・胆管炎の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Taiho Pharmaceutical、Mayo Clinic、Bayer、Gilead Sciences、RiemserArzneimittel、Zambon） ・胆管炎の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cholangitis is an infection of the biliary tract with the potential to cause significant morbidity and mortality.The key factors contributing to the growth of the cholangitis market are the changing lifestyle, increasing awareness of healthcare and geriatric population increase.
In 2018, the global Cholangitis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cholangitis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cholangitis development in United States, Europe and China.
The key players covered in this study
Taiho Pharmaceutical
Mayo Clinic
Bayer
Gilead Sciences
RiemserArzneimittel
Zambon
…
Market segment by Type, the product can be split into
Acute Cholangitis
Primary Sclerosing Cholangitis
Secondary Sclerosing Cholangitis
Recurrent Pyogenic Cholangitis
Market segment by Application, split into
Clinical Practise
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cholangitis status, future forecast, growth opportunity, key market and key players.
To present the Cholangitis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cholangitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cholangitis Market Size Growth Rate by Type (2014-2025)
1.4.2 Acute Cholangitis
1.4.3 Primary Sclerosing Cholangitis
1.4.4 Secondary Sclerosing Cholangitis
1.4.5 Recurrent Pyogenic Cholangitis
1.5 Market by Application
1.5.1 Global Cholangitis Market Share by Application (2014-2025)
1.5.2 Clinical Practise
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cholangitis Market Size
2.2 Cholangitis Growth Trends by Regions
2.2.1 Cholangitis Market Size by Regions (2014-2025)
2.2.2 Cholangitis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cholangitis Market Size by Manufacturers
3.1.1 Global Cholangitis Revenue by Manufacturers (2014-2019)
3.1.2 Global Cholangitis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cholangitis Market Concentration Ratio (CR5 and HHI)
3.2 Cholangitis Key Players Head office and Area Served
3.3 Key Players Cholangitis Product/Solution/Service
3.4 Date of Enter into Cholangitis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cholangitis Market Size by Type (2014-2019)
4.2 Global Cholangitis Market Size by Application (2014-2019)
5 United States
5.1 United States Cholangitis Market Size (2014-2019)
5.2 Cholangitis Key Players in United States
5.3 United States Cholangitis Market Size by Type
5.4 United States Cholangitis Market Size by Application
6 Europe
6.1 Europe Cholangitis Market Size (2014-2019)
6.2 Cholangitis Key Players in Europe
6.3 Europe Cholangitis Market Size by Type
6.4 Europe Cholangitis Market Size by Application
7 China
7.1 China Cholangitis Market Size (2014-2019)
7.2 Cholangitis Key Players in China
7.3 China Cholangitis Market Size by Type
7.4 China Cholangitis Market Size by Application
8 Japan
8.1 Japan Cholangitis Market Size (2014-2019)
8.2 Cholangitis Key Players in Japan
8.3 Japan Cholangitis Market Size by Type
8.4 Japan Cholangitis Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cholangitis Market Size (2014-2019)
9.2 Cholangitis Key Players in Southeast Asia
9.3 Southeast Asia Cholangitis Market Size by Type
9.4 Southeast Asia Cholangitis Market Size by Application
10 India
10.1 India Cholangitis Market Size (2014-2019)
10.2 Cholangitis Key Players in India
10.3 India Cholangitis Market Size by Type
10.4 India Cholangitis Market Size by Application
11 Central & South America
11.1 Central & South America Cholangitis Market Size (2014-2019)
11.2 Cholangitis Key Players in Central & South America
11.3 Central & South America Cholangitis Market Size by Type
11.4 Central & South America Cholangitis Market Size by Application
12 International Players Profiles
12.1 Taiho Pharmaceutical
12.1.1 Taiho Pharmaceutical Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cholangitis Introduction
12.1.4 Taiho Pharmaceutical Revenue in Cholangitis Business (2014-2019)
12.1.5 Taiho Pharmaceutical Recent Development
12.2 Mayo Clinic
12.2.1 Mayo Clinic Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cholangitis Introduction
12.2.4 Mayo Clinic Revenue in Cholangitis Business (2014-2019)
12.2.5 Mayo Clinic Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cholangitis Introduction
12.3.4 Bayer Revenue in Cholangitis Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Gilead Sciences
12.4.1 Gilead Sciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cholangitis Introduction
12.4.4 Gilead Sciences Revenue in Cholangitis Business (2014-2019)
12.4.5 Gilead Sciences Recent Development
12.5 RiemserArzneimittel
12.5.1 RiemserArzneimittel Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cholangitis Introduction
12.5.4 RiemserArzneimittel Revenue in Cholangitis Business (2014-2019)
12.5.5 RiemserArzneimittel Recent Development
12.6 Zambon
12.6.1 Zambon Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cholangitis Introduction
12.6.4 Zambon Revenue in Cholangitis Business (2014-2019)
12.6.5 Zambon Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cholangitis Key Market Segments
Table Key Players Cholangitis Covered
Table Global Cholangitis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cholangitis Market Size Market Share by Type 2014-2025
Figure Acute Cholangitis Figures
Table Key Players of Acute Cholangitis
Figure Primary Sclerosing Cholangitis Figures
Table Key Players of Primary Sclerosing Cholangitis
Figure Secondary Sclerosing Cholangitis Figures
Table Key Players of Secondary Sclerosing Cholangitis
Figure Recurrent Pyogenic Cholangitis Figures
Table Key Players of Recurrent Pyogenic Cholangitis
Table Global Cholangitis Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinical Practise Case Studies
Figure Others Case Studies
Figure Cholangitis Report Years Considered
Table Global Cholangitis Market Size 2014-2025 (Million US$)
Figure Global Cholangitis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cholangitis Market Size by Regions 2014-2025 (Million US$)
Table Global Cholangitis Market Size by Regions 2014-2019 (Million US$)
Table Global Cholangitis Market Share by Regions 2014-2019
Figure Global Cholangitis Market Share by Regions 2014-2019
Figure Global Cholangitis Market Share by Regions 2019
Table Market Top Trends
Table Global Cholangitis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cholangitis Market Share by Manufacturers (2014-2019)
Figure Global Cholangitis Market Share by Manufacturers in 2018
Table Global Cholangitis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cholangitis Product/Solution/Service
Table Date of Enter into Cholangitis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cholangitis Market Size by Type (2014-2019) (Million US$)
Table Global Cholangitis Market Size Share by Type (2014-2019)
Figure Global Cholangitis Market Size Market Share by Type (2014-2019)
Table Global Cholangitis Market Size by Application (2014-2019) (Million US$)
Table Global Cholangitis Market Size Share by Application (2014-2019)
Figure Global Cholangitis Market Size Market Share by Application (2014-2019)
Figure Global Cholangitis Revenue Market Share by Application in 2018
Figure United States Cholangitis Market Size 2014-2019 (Million US$)
Table United States Key Players Cholangitis Revenue (2018-2019) (Million US$)
Table United States Key Players Cholangitis Market Share (2018-2019)
Table United States Cholangitis Market Size by Type (2014-2019) (Million US$)
Table United States Cholangitis Market Share by Type (2014-2019)
Table United States Cholangitis Market Size by Application (2014-2019) (Million US$)
Table United States Cholangitis Market Share by Application (2014-2019)
Figure Europe Cholangitis Market Size 2014-2019 (Million US$)
Table Europe Key Players Cholangitis Revenue (2018-2019) (Million US$)
Table Europe Key Players Cholangitis Market Share (2018-2019)
Table Europe Cholangitis Market Size by Type (2014-2019) (Million US$)
Table Europe Cholangitis Market Share by Type (2014-2019)
Table Europe Cholangitis Market Size by Application (2014-2019) (Million US$)
Table Europe Cholangitis Market Share by Application (2014-2019)
Figure China Cholangitis Market Size 2014-2019 (Million US$)
Table China Key Players Cholangitis Revenue (2018-2019) (Million US$)
Table China Key Players Cholangitis Market Share (2018-2019)
Table China Cholangitis Market Size by Type (2014-20189) (Million US$)
Table China Cholangitis Market Share by Type (2014-2019)
Table China Cholangitis Market Size by Application (2014-2019) (Million US$)
Table China Cholangitis Market Share by Application (2014-2019)
Figure Japan Cholangitis Market Size 2014-2019 (Million US$)
Table Japan Key Players Cholangitis Revenue (2018-2019) (Million US$)
Table Japan Key Players Cholangitis Market Share (2018-2019)
Table Japan Cholangitis Market Size by Type (2014-2019) (Million US$)
Table Japan Cholangitis Market Share by Type (2014-2019)
Table Japan Cholangitis Market Size by Application (2014-2019) (Million US$)
Table Japan Cholangitis Market Share by Application (2014-2019)
Figure Southeast Asia Cholangitis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cholangitis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cholangitis Market Share (2018-2019)
Table Southeast Asia Cholangitis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cholangitis Market Share by Type (2014-2019)
Table Southeast Asia Cholangitis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cholangitis Market Share by Application (2014-2019)
Figure India Cholangitis Market Size 2014-2019 (Million US$)
Table India Key Players Cholangitis Revenue (2018-2019) (Million US$)
Table India Key Players Cholangitis Market Share (2018-2019)
Table India Cholangitis Market Size by Type (2014-2019) (Million US$)
Table India Cholangitis Market Share by Type (2014-2019)
Table India Cholangitis Market Size by Application (2014-2019) (Million US$)
Table India Cholangitis Market Share by Application (2014-2019)
Figure Central & South America Cholangitis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cholangitis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cholangitis Market Share (2018-2019)
Table Central & South America Cholangitis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cholangitis Market Share by Type (2014-2019)
Table Central & South America Cholangitis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cholangitis Market Share by Application (2014-2019)
Table Taiho Pharmaceutical Company Details
Table Taiho Pharmaceutical Revenue in Cholangitis Business (2014-2019) (Million US$)
Figure Taiho Pharmaceutical Revenue Growth Rate in Cholangitis Business (2014-2019)
Table Taiho Pharmaceutical Recent Development
Table Mayo Clinic Company Details
Table Mayo Clinic Revenue in Cholangitis Business (2014-2019)(Million US$)
Figure Mayo Clinic Revenue Growth Rate in Cholangitis Business (2014-2019)
Table Mayo Clinic Recent Development
Table Bayer Company Details
Table Bayer Revenue in Cholangitis Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Cholangitis Business (2014-2019)
Table Bayer Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Cholangitis Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Cholangitis Business (2014-2019)
Table Gilead Sciences Recent Development
Table RiemserArzneimittel Company Details
Table RiemserArzneimittel Revenue in Cholangitis Business (2014-2019)(Million US$)
Figure RiemserArzneimittel Revenue Growth Rate in Cholangitis Business (2014-2019)
Table RiemserArzneimittel Recent Development
Table Zambon Company Details
Table Zambon Revenue in Cholangitis Business (2014-2019)(Million US$)
Figure Zambon Revenue Growth Rate in Cholangitis Business (2014-2019)
Table Zambon Recent Development
Table Global Cholangitis Market Size by Regions (Million US$) 2019-2025
Figure Global Cholangitis Market Size Share by Regions (2019-2025)
Figure Global Cholangitis Market Size Share by Regions in 2025
Figure United States Cholangitis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cholangitis Market Size Forecast (2019-2025)(Million USD)
Figure China Cholangitis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cholangitis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cholangitis Market Size Forecast (2019-2025)(Million USD)
Figure India Cholangitis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cholangitis Market Size Forecast (2019-2025)(Million USD)
Table Global Cholangitis Market Size by Product (2019-2025) (Million US$)
Figure Global Cholangitis Market Size by Product (2019-2025)
Figure Global Cholangitis Market Size by Product in 2025
Table Global Cholangitis Market Size by Application (2019-2025) (Million US$)
Figure Global Cholangitis Market Size by Application (2019-2025)
Figure Global Cholangitis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
原発性胆管炎治療薬の世界市場：市場規模・現状・予測 Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver.There is a dire need for curative therapy for primary biliary cholangitis across the world. This is because of the recurring nature of the disease. Currently, the only cure for the…- 再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx milli…
- 再発多形性膠芽腫（GBM）治療の世界市場：市場規模・現状・予測 Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain.The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. In 2018, the global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was xx milli…
- 急性反復発作の世界市場：市場規模・現状・予測 Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG.In 2018, the global Acute Repetitive Seizures market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the…
- 急性腎不全治療薬の世界市場：市場規模・現状・予測 Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body.Acute ren…